Hypermarcas Signs Agreement With Ache, EMS and Uniao Quimica
Hypermarcas SA (HYPE3) signed an agreement with Ache Laboratorios Farmaceuticos SA, EMS Participacoes SA e Uniao Quimica Farmaceutica Nacional SA to form a joint venture and create Bionovis SA, a biotechnical company that plans to invest 500 million reais in the next five years, according to a regulatory filing.
Hypermarcas will hold a 25 percent stake in the joint venture.
To contact the reporter on this story: Telma Marotto in Sao Paulo at email@example.com
To contact the editor responsible for this story: Francisco Marcelino at firstname.lastname@example.org